FLuorescence Guided Assessment of Mesenteric Ischemia in Emergency Surgery
FLAMES
Intraoperative Intestinal Perfusion Assessment by Fluorescence Angiography in Emergency Surgery
1 other identifier
interventional
100
1 country
5
Brief Summary
This is a prospective, multicentre, non-randomized cohort study using real-time intraoperative visualization of bowel perfusion by indocyanine green (ICG) in all-cause bowel ischemia. At intraoperative finding of bowel ischemia, the initial intraoperative plan is noted and resection margins marked with a steril pen. A fluorescence angiography will be performed and the surgeon will note whether the suspected ischemic bowel is perfused, whether there is a change in the resection margins in centimeters, and if the intraoperative plan has changed. If resection is indicated and the strategy of choice is an anastomosis, a renewed fluorescence angiography will be performed to assess anastomotic perfusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2024
CompletedFirst Submitted
Initial submission to the registry
March 8, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
November 15, 2024
November 1, 2024
2.7 years
March 8, 2024
November 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of strategy
Change of intraoperative strategy due to ICG fluorescence angiography. Intraoperatively, a nurse will record the initial strategy, indication of resection in centimeters, before and after ICG angiography, and note whether there has been a change in strategy, and how.
Assessed at day 30 and 90 after surgery
Secondary Outcomes (8)
Anastomosis
Assessed at day 30 and 90 after surgery
Quantification using q-ICG
30 months
Stomas
Assessed at day 30 and 90 after surgery
Second-look
Assessed at day 30 and 90 after surgery
Anastomotic leaks
Assessed at day 30 and 90 after surgery
- +3 more secondary outcomes
Study Arms (1)
single arm
OTHERInterventions
Intraoperative perfusion assessment with ICG Fluorescence Angiography (ICG-FA) in standard approved doses
Eligibility Criteria
You may qualify if:
- Adult patients \>18 years of age
- Acute physiologic derangement and suspected of having bowel ischemia
- Intraoperative finding of all-cause bowel ischemia with subsequent acute physiologic derangement
You may not qualify if:
- Allergy toward; iodine, indocyanine green, or shellfish
- Liver insufficiency
- Thyrotoxicosis
- Pregnancy or lactation
- Permanently legally incompetent for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Department of Organ Surgery and Transplantation
Copenhagen, Capital Region, 2100, Denmark
Department of Surgery, Bispebjerg Hospital
Bispebjerg, Denmark
Department of Surgery, Herlev Hospital
Herlev, Denmark
Department of Surgery, Nordsjællands Hospital
Hillerød, Denmark
Department of Surgery, Hvidovre Hospital
Hvidovre, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sermed Ellebæk Nicolae, MD, PhDstudent
Rigshospitalet, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD, PhD, DMSc
Study Record Dates
First Submitted
March 8, 2024
First Posted
March 21, 2024
Study Start
March 5, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share